CHASE AORTIC PERFUSION CANNULA— 510(k) K970914

Substantially Equivalent

Chase Medical, Inc.

FDA 510(k) clearance K970914 for CHASE AORTIC PERFUSION CANNULA, Substantially Equivalent on 1997-05-13. Applicant: Chase Medical, Inc..

Clearance details

Applicant: Chase Medical, Inc.
Product code: Code DWF
Advisory panel: Cardiovascular
Date received: 1997-03-12
Decision date: 1997-05-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Richardson, TX, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DWF

product code DWF

Death: 106
Injury: 386
Malfunction: 2,323
Total: 2,815

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.